China Shineway Pharmaceutical Declares RMB 0.80 Second Interim Dividend for FY 2026

Bulletin Express

Aug 27

China Shineway Pharmaceutical Group Limited announced on 27 August 2026 a second interim ordinary dividend of RMB 0.80 per share for the financial year ending 31 December 2026. Based on the declared exchange rate of RMB 1 to HKD 1.166, the dividend corresponds to HKD 0.933 per share for shareholders on the Hong Kong register.

Key timetable: • Ex-dividend date: 9 September 2026 • Last day to lodge transfers: 10 September 2026 (by 16:30) • Book-closure period: 11–14 September 2026 • Record date: 14 September 2026 • Payment date: 25 September 2026

Shareholder approval is not required for this distribution. The company also confirmed that no withholding tax will be applied and there are no listed warrants or convertible securities associated with this announcement.

Directors as at the announcement date are Executive Directors Li Zhenjiang, Xin Yunxia and Li Huimin; Non-executive Director Zhou Wencheng; and Independent Non-executive Directors Liu Shun Fai, Yew Yat On and Wang Guihua.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg.tigeractivity.com/news/1120011070"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1120011070\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1120011070?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-08-27 12:23","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1120011070","market":"us","top_or_hot":-1,"title":"China Shineway Pharmaceutical Declares RMB 0.80 Second Interim Dividend for FY 2026","media":"Bulletin Express","content":"<p>China Shineway Pharmaceutical Group Limited announced on 27 August 2026 a second interim ordinary dividend of RMB 0.80 per share for the financial year ending 31 December 2026. Based on the declared exchange rate of RMB 1 to HKD 1.166, the dividend corresponds to HKD 0.933 per share for shareholders on the Hong Kong register.</p>\n<p>Key timetable:\n• Ex-dividend date: 9 September 2026  \n• Last day to lodge transfers: 10 September 2026 (by 16:30)  \n• Book-closure period: 11–14 September 2026  \n• Record date: 14 September 2026  \n• Payment date: 25 September 2026</p>\n<p>Shareholder approval is not required for this distribution. The company also confirmed that no withholding tax will be applied and there are no listed warrants or convertible securities associated with this announcement.</p>\n<p>Directors as at the announcement date are Executive Directors Li Zhenjiang, Xin Yunxia and Li Huimin; Non-executive Director Zhou Wencheng; and Independent Non-executive Directors Liu Shun Fai, Yew Yat On and Wang Guihua.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>China Shineway Pharmaceutical Declares RMB 0.80 Second Interim Dividend for FY 2026</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nChina Shineway Pharmaceutical Declares RMB 0.80 Second Interim Dividend for FY 2026\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-08-27 12:23</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>China Shineway Pharmaceutical Group Limited announced on 27 August 2026 a second interim ordinary dividend of RMB 0.80 per share for the financial year ending 31 December 2026. Based on the declared exchange rate of RMB 1 to HKD 1.166, the dividend corresponds to HKD 0.933 per share for shareholders on the Hong Kong register.</p>\n<p>Key timetable:\n• Ex-dividend date: 9 September 2026  \n• Last day to lodge transfers: 10 September 2026 (by 16:30)  \n• Book-closure period: 11–14 September 2026  \n• Record date: 14 September 2026  \n• Payment date: 25 September 2026</p>\n<p>Shareholder approval is not required for this distribution. The company also confirmed that no withholding tax will be applied and there are no listed warrants or convertible securities associated with this announcement.</p>\n<p>Directors as at the announcement date are Executive Directors Li Zhenjiang, Xin Yunxia and Li Huimin; Non-executive Director Zhou Wencheng; and Independent Non-executive Directors Liu Shun Fai, Yew Yat On and Wang Guihua.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02877","symbol_name":"神威药业","start_time":0,"source_url":"","article_id":"1120011070","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1120011070","pubTimestamp":1787804608,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"China Shineway Pharmaceutical Group Limited announced on 27 August 2026 a second interim ordinary dividend of RMB 0.80 per share for the financial year ending 31 December 2026. Based on the declared...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02877":"神威药业"},"translate_title":"中国神威药业宣布2026财年第二次中期股息0.80元","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02877":1},"content_text":"China Shineway Pharmaceutical Group Limited announced on 27 August 2026 a second interim ordinary dividend of RMB 0.80 per share for the financial year ending 31 December 2026. Based on the declared exchange rate of RMB 1 to HKD 1.166, the dividend corresponds to HKD 0.933 per share for shareholders on the Hong Kong register.\nKey timetable:\n• Ex-dividend date: 9 September 2026  \n• Last day to lodge transfers: 10 September 2026 (by 16:30)  \n• Book-closure period: 11–14 September 2026  \n• Record date: 14 September 2026  \n• Payment date: 25 September 2026\nShareholder approval is not required for this distribution. The company also confirmed that no withholding tax will be applied and there are no listed warrants or convertible securities associated with this announcement.\nDirectors as at the announcement date are Executive Directors Li Zhenjiang, Xin Yunxia and Li Huimin; Non-executive Director Zhou Wencheng; and Independent Non-executive Directors Liu Shun Fai, Yew Yat On and Wang Guihua.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}